- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Torrent pharma successfully completes USFDA inspection for Levittown facility
Ahmedabad: Torrent Pharma has recently announced that the US Food and Drug Administration (USFDA) has successfully concluded inspection at its Levittown, Pennsylvania, USA manufacturing facility.The inspection was conducted between 6th December 2021 and 15th December 2021."This is to inform that our Levittown, Pennsylvania, USA manufacturing facility was inspected by USFDA between 6 th...
Ahmedabad: Torrent Pharma has recently announced that the US Food and Drug Administration (USFDA) has successfully concluded inspection at its Levittown, Pennsylvania, USA manufacturing facility.
The inspection was conducted between 6th December 2021 and 15th December 2021.
"This is to inform that our Levittown, Pennsylvania, USA manufacturing facility was inspected by USFDA between 6 th December 2021 and 15th December 2021,"the company said in a BSE filing.
At the end of the inspection, No Form 483 was issued.
"It is a positive development for the Company and is a reflection of our commitment to consistency in quality and compliance with regulatory standards," the company added.
Read also: Torrent pharma gets CDSCO nod to market additional strength of Amlodipine,Olmesartan Medoxomil FDC
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751